Form 4: Lumentum Director Sells 10,000 Shares Under Pre-Arranged Trading Plan
Insider Transaction Report
Lumentum Holdings Inc. Director Alan S. Lowe sold 10,000 shares of common stock for $83.58 per share on June 4, 2025, as part of a Rule 10b5-1 trading plan.
Summary
- Alan S. Lowe, a Director of Lumentum Holdings Inc. (LITE), reported a transaction on June 4, 2025.
- He sold 10,000 shares of Lumentum common stock at a price of $83.58 per share.
- The sale was executed under a pre-arranged Rule 10b5-1 trading plan, which was adopted on November 20, 2024.
- Following this transaction, Mr. Lowe beneficially owns 270,471 shares of Lumentum common stock.
- His total beneficial ownership includes 561 shares acquired through the company's Employee Stock Purchase Plan on November 15, 2023, May 15, 2024, and November 15, 2024.
Sentiment
Score: 5
Explanation: Neutral. This is a routine insider sale under a pre-arranged plan, which is common and doesn't necessarily indicate a negative outlook on the company. The director still holds a substantial number of shares, suggesting continued alignment with shareholder interests.
Positives
- The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than a reaction to immediate market conditions, which often mitigates concerns about opportunistic selling.
- The director still retains a significant holding of 270,471 shares, demonstrating continued alignment with shareholder interests.
- The director has participated in the Employee Stock Purchase Plan, acquiring additional shares over time, which can be seen as a positive sign of long-term commitment.
Negatives
- A director selling shares, even under a pre-arranged plan, could be perceived negatively by some investors as it reduces their direct stake in the company.
Future Outlook
This Form 4 filing reports a past transaction and does not contain forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This Form 4 filing is a routine disclosure of an insider stock transaction and does not provide information directly related to broader industry trends or competitive landscape. Insider transactions are common across all industries and are typically driven by personal financial planning rather than specific industry-wide events, especially when executed under a Rule 10b5-1 plan.
Comparison to Industry Standards
- Form 4 filings are standard regulatory disclosures for insider transactions in the U.S. market, ensuring transparency in executive and director stock dealings.
- The execution of a sale under a Rule 10b5-1 plan is a common and accepted practice among corporate insiders to manage personal finances while avoiding accusations of trading on material non-public information, aligning with best practices for insider trading compliance.
- There are no specific comparable companies, projects, or financial results mentioned in this filing to assess against broader industry performance standards.
Stakeholder Impact
- Shareholders: The sale by a director might be viewed with slight caution by some, but the pre-arranged nature (Rule 10b5-1 plan) mitigates concerns about opportunistic selling. The director's remaining significant stake suggests continued alignment with shareholder interests.
Key Dates
| Date | Description |
|---|---|
| 11/15/2023 | Shares acquired via Issuer's Employee Stock Purchase Plan. |
| 05/15/2024 | Shares acquired via Issuer's Employee Stock Purchase Plan. |
| 11/15/2024 | Shares acquired via Issuer's Employee Stock Purchase Plan. |
| 11/20/2024 | Rule 10b5-1 trading plan adopted by the Reporting Person. |
| 06/04/2025 | Date of common stock sale by Alan S. Lowe. |
| 06/06/2025 | Signature date of the Form 4 filing. |
Recommendation
holdKeywords
Lumentum Holdings Inc., LITE, Form 4, Insider Trading, Stock Sale, Director, Alan S. Lowe, Rule 10b5-1, Beneficial Ownership, Employee Stock Purchase Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.